Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review von Zarogoulidis, P, Chatzaki, E, Hohenforst-Schmidt, W, Goldberg, E P, Galaktidou, G, Kontakiotis, T, Karamanos, N, Zarogoulidis, K

Volltext

Long acting somatostatin analogues in combination to antineoplastic agents in the treatment of small cell lung cancer patients von Zarogoulidis, K, Eleftheriadou, E, Kontakiotis, Th, Gerasimou, G, Zarogoulidis, P, Sapardanis, I, Galaktidou, G, Sakkas, L, Gotzamani-Psarrakou, A, Karatzas, N

Volltext

Profiling serum HER-2/NEU in prostate cancer von Siampanopoulou, M, Galaktidou, G, Dimasis, N, Gotzamani-Psarrakou, A

Volltext

Plasma vascular endothelial growth factor and angiogenin are positively related to erythropoietin dose in hemodialysis patients von Eleftheriadis, T, Antoniadi, G, Liakopoulos, V, Pissas, G, Galaktidou, G, Stefanidis, I

Volltext

Suppression of humoral immune response to hepatitis B surface antigen vaccine in BALB/c mice by 1-methyl-tryptophan co-administration von Eleftheriadis, T, Sparopoulou, T, Antoniadi, G, Liakopoulos, V, Stefanidis, I, Galaktidou, G

Volltext

Dexamethasone plus octreotide regimen increases anticancer effects of docetaxel on TRAMP-C1 prostate cancer model von Dalezis, P, Geromichalos, G D, Trafalis, D T, Pissimissis, N, Panagiotopoulou, D, Galaktidou, G, Papageorgiou, E, Papageorgiou, A, Daifoti, Z, Lymperi, M, Koutsilieris, M

Volltext

Lipopolysaccharide and hypoxia significantly alters interleukin-8 and macrophage chemoattractant protein-1 production by human fibroblasts but not fibrosis related factors von Eleftheriadis, T, Liakopoulos, V, Lawson, B, Antoniadi, G, Stefanidis, I, Galaktidou, G

Volltext

The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refrac... von Hatjiharissi, E., Terpos, E., Papaioannou, M., Hatjileontis, C., Kaloutsi, V., Galaktidou, G., Gerotziafas, G., Christakis, J., Zervas, K.

Volltext

0051 Serum VEGF-C and serum VEGF-R2 in patients with triple negative breast cancer von Iosifidou, R, Galaktidou, G, Lola, D, Papanikolaou, A, Vladika, N, Patakiouta, F, Bousoulegas, A

Volltext

Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer von Boutsikou, Eftimia, Kontakiotis, Theodoros, Zarogoulidis, Paul, Darwiche, Kaid, Eleptheriadou, Ellada, Porpodis, Konstantinos, Galaktidou, Grammati, Sakkas, Leonidas, Hohenforst-Schmidt, Wolfgang, Tsakiridis, Kosmas, Karaiskos, Theodoros, Zarogoulidis, Konstantinos

Volltext

2011 POSTER Serum BCL-2 and VEGF in women with breast cancer – can they detect the recurrence before CEA and CA15–3? von Iosifidou, R, Galaktidou, G, Patakiouta, F, Bousoulegas, A

Volltext

7048 Elevated serum her2/neu in human prostate cancer and benign hyperplasia von Siampanopoulou, M, Dimasis, N, Galaktidou, G, Zaromitidou, E, Peftoulidis, S, Sioundas, A, Haritanti, A, Gotzamani-Psarrakou, A

Volltext

Serum EGFR and serum HER2 in patients with triple negative breast cancer von Iosifidou, R, Galaktidou, G, Albanaki, X.R, Mameletzi, S, Vladika, N, Patakiouta, F, Bousoulegas, A

Volltext

Interferon-α2b treatment of chronic hepatitis C in haemodialysis patients von RAPTOPOULOU-GIGI, M, SPAIA, S, MAVROUDI, I, EFKARPIDOU, A, KORTSARIS, A, GARIFALLOS, A, XENOU, P, ORPHANOU, H, ZARFIDOU, E, PETRIDOU, P, VRETTOU, H, VAGIONAS, G, GALAKTIDOU, G

Volltext

L-arginine supplementation does not affect chemically induced carcinogenesis and tumor growth in BALB-c mice von Eleftheriadis, T, Voyatzi, S, Sparopoulou, T, Kartsios, C, Yiannaki, E, Antoniadi, G, Liakopoulos, V, Galaktidou, G

Volltext

Targeting therapies influence survival of refractory patients with advanced lung adenocarcinoma: A phase II randomized trial von Zarogoulidis, K., Boutsikou, E., Kontakiotis, T., Zarogoulidis, P., Eleftheriadou, E., Sacas, L., Galaktidou, G.

Volltext

Long-acting somatostatin analogues survival differences in limited- and extensive-disease SCLC patients von Zarogoulidis, K., Eleftheriadou, E., Gerasimou, G., Zarogoulidis, P., Sapardanis, I., Kontakiotis, T., Galaktidou, G., Gotzamani-Psarrakou, A., Karatzas, N.

Volltext

VEGF-A, VEGF-C, VEGF-R2, EGFR and HER2 in serum plus EGFR in tissue of patients with triple-negative breast cancer von Iosifidou, R, Galaktidou, G, Ananiadis, A, Bladika, N, Patakiouta, F, Bousoulegas, A

Volltext

Serum proangiogenic factors in patients with testicular germ cell tumors von Boutis, A. L., Diamantopoulos, N., Mouratidou, D., Andreadis, C., Galaktidou, G., Papazisis, K., Lalla, E., Kortsaris, A.

Volltext

273 POSTER The prognostic value of serum VEGF, c-erb-B2, p53m and bcl-2 in women with breast cancer, can they detect the recurrence before the clinical appearance? von Iosifidou, R., Galaktidou, G., Patakiouta, F., Bousoulegas, A.

Volltext